Language： 简体中文 English
Your location： Home > Program
Print Program Outline Speakers
Query：
Date：
  • All
  • November 19, 2026
  • November 20, 2026
  • November 21, 2026
Hall：
  • All
  • 5th‑Floor Grand Ballroom
  • S101
  • S102
  • S103
  • S105
  • S106
  • S107
  • S109
  • S110
  • S111
  • S201
  • S202
  • S203
  • S204
  • S205
  • S206
  • S207
  • V11
  • V22
  • V23
  • V24
  • V25
  • InterContinental Ballroom 1
Subject：
  • All
  • Plenary Session
  • Oncology
  • Minimally Invasive Surgery
  • Stones
  • Incontinence
  • Robotic Surgery
  • Clinical Research
  • Basic and Translational Science
  • Female Urology
  • Andrology
  • Nursing
  • Infection
  • Renal Transplantation
  • Laser Surgery
  • Community Urology
  • Reconstructive Surgery
  • Adrenals
  • Pediatric Urology
  • Smart Surgery
  • Urological Engineering
  • Special Session
  • Prostate Cancer Pathfinders: Evidence into Action
  • Prostate Neoplasms Session
  • Benign Diseases Diagnosis & Treatment Session
  • Urolithiasis Standardized Care Project
  • Discovering Urological Frontiers
  • Urology & Prostate
  • Rising Leaders Urology
  • Urologic Oncology Session
  • Training Program for Urological Department
  • Precision Care in Urologic Oncology
  • Uro-Oncology Leadership & Innovation Forum
  • Remote Session: Normalized Surgical Practice
  • RCC Immunotherapy Session
  • Intelligent Leadership in Prostate Care
  • Bladder Cancer Session
  • MP + SP in URO Seminar
  • Benign Prostatic Hyperplasia Session
  • Ingenuity Exploration
  • Renal Cell Carcinoma Session
  • Prostate Cancer Session

November 19, 2026

S202

November 19, 2026 13:00-13:05 Part I: Innovation and Advancing Treatment Goals Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Fan Cheng China
1 13:00-13:05

Opening Remarks and Academic Inauguration

Xu Zhang China
Shaogang Wang China
November 19, 2026 13:05-13:10 Scientific Presentation Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Xin Ma China
1 13:05-13:10

A New Chapter in Evidence and Long-Term Outcomes: Scientific Presentation of Long-Term Overall Survival (OS) Follow-up Results from the CHART Study

Xu Zhang China
Tianxin Lin China
Linhui Wang China
Yuanjie Niu China
Jianbin Bi China
Guohua Zeng China
Qiang Wei China
Shaogang Wang China
Ji Feng China
November 19, 2026 13:10-13:20 Symposium Prostate Cancer Pathfinders: Evidence into Action
1 13:10-13:20

Innovation with a Long-Term Vision: Advances in the Urologic Oncology R&D Pipeline and Clinical Development

Xiaojian Xu China
November 19, 2026 13:20-13:30 Expert Discussion Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Xiaojian Xu China
1 13:20-13:30

How Can Clinical Needs Guide Coordinated Progress in Urologic Oncology Innovation and Clinical Practice?

Xu Zhang China
Tianxin Lin China
Qiang Wei China
Shaogang Wang China
Yejiabin Qi China
November 19, 2026 13:30-13:45 Keynote Lecture Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Nianzeng Xing China
1 13:30-13:45

Evidence-Based Standards: Updates to China and International Prostate Cancer Guidelines and Evolving Care Pathways

Jia Hu China
November 19, 2026 13:45-14:00 Keynote Lecture Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Dingwei Ye China 丨 Kunjie Wang China
1 13:45-14:00

Beginning with the End in Mind: Long-Term Benefits and Evolving Treatment Goals in Prostate Cancer

Peng Wu China
November 19, 2026 14:00-14:15 Keynote Lecture Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Shaogang Wang China 丨 Kunjie Wang China
1 14:00-14:15

From AI-Enhanced Fusion Biopsy to Transperineal Focal Therapy: The Evolving Role of UroFusion in Precision Prostate Cancer Care

Marco Oderda Italy
November 19, 2026 14:15-14:55 Part II: Sound Practice and Long-Term Treatment Decisions (I)Session 1: Earlier Intervention and Key Perioperative Decisions Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Xin Yao China 丨 Lin Qi China 丨 Weijun Qin China 丨 Bing Li China
1 14:15-14:30

High-Risk Localized or Locally Advanced Prostate Cancer: Surgical Selection and Timing after Intensified Neo-adjuvant Therapy

Yuliang Xue China
2 14:30-14:45

High Risk of Recurrence after Radical Prostatectomy: PSA Dynamics, PSMA PET, and Timing of Early Salvage Treatment

Yuliang Xue China
3 14:45-14:55

Can Treatment Move Forward? Coordinating Perioperative Systemic Therapy, Local Treatment, and Recurrence Risk Management

Ming Chen China
Lingwu Chen China
Weiyang He China
Jianning Wang China
November 19, 2026 14:55-15:35 Part II: Sound Practice and Long-Term Treatment Decisions (I)Session 2: Appropriate Intensification, Initial Decisions, and Long-Term Benefits in mHSPC Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Tie Chong China 丨 Dan Xia China 丨 Haowen Jiang China 丨 Yang Wang China
1 14:55-15:10

Newly Diagnosed High-Risk mHSPC: Doublet or Triplet Therapy? Individualized Selection Based on Disease Risk and Patient Characteristics

- China
2 15:10-15:25

From Rapid Tumor Control to Long-Term Management: Balancing Efficacy, Safety, Adherence, and Quality of Life in mHSPC

- China
3 15:25-15:35

Intensification Means More than Adding Treatments: Integrating Tumor Burden, Disease Risk, Fitness for Chemotherapy, and Long-Term Goals when Selecting Initial Therapy

Zhuowei Liu China
Bangmin Han China
Benkang Shi China
Zhiyu Liu China
Xin Li China
November 19, 2026 15:35-16:15 Part II: Sound Practice and Long-Term Treatment Decisions (II)Session 3: Evidence for Precision Care, Stratification, and Sequencing in mCRPC Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Xuesong Li China 丨 Ming Liu China 丨 Gonghui Li China 丨 Sanxiang Li China
1 15:35-15:50

Earlier Testing: How HRR Gene Alteration Stratification Can Optimize First-Line Treatment Decisions in mCRPC

- China
2 15:50-16:05

From AR Pathway Inhibition to PARPi and AR Pathway Synergy: Evidence, Patient Selection, and Practical Considerations for Precision Combination Therapy

- China
3 16:05-16:15

How Can Precised First-Line Treatment in mCRPC Be Implemented while Preserving Subsequent Sequencing Options?

Chunxi Wang China
Xinquan Gu China
Liefu Ye China
Zhenhua Li China
November 19, 2026 16:15-16:50 Part II: Sound Practice and Long-Term Treatment Decisions (II)Session 4: Advanced Decision-Making and Comprehensive Care in Complex Clinical Scenarios Prostate Cancer Pathfinders: Evidence into Action
Moderator ：
Tao Xu China 丨 Xiaoming Cao China 丨 Jinchun Xing China 丨 Jun Xiao China
1 16:15-16:30

Rethinking Treatment Decisions while Facing Multiple Clinical Challenges

- China
2 16:30-16:45

Practical Lessons in Moving from Individual Interventions to Comprehensive Care

- China
3 16:45-16:55

How Can an Actionable and Sustainable Comprehensive Care Plan Be Built for Heterogeneous Disease Courses and Patient Needs?

Xiaoping Zhang China
Yifei Xing China
Aili Zhang China
Yinhuai Wang China
November 19, 2026 16:55-17:00 Summary Prostate Cancer Pathfinders: Evidence into Action
1 16:55-17:00

Summary

Conference Congress Steering Committee China